Evidence map›Paper›PMID 23428641›Full record

ArticleBioinformatics (Oxford, England)2013

EBSeq: an empirical Bayes hierarchical model for inference in RNA-seq experiments.

Ning Leng, John A Dawson, James A Thomson, Victor Ruotti, Anna I Rissman, Bart M G Smits, Jill D Haag, Michael N Gould, Ron M Stewart, Christina Kendziorski

Erratum issued Registry-linked trialAbstract read
In one paragraph

Article in Bioinformatics (Oxford, England), 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. It is linked to trial NCT03529955 (A Phase 2, Open Label Single Arm Study for Evaluating Safety & Efficacy of Apremilast in the Treatment of Cutaneous Disease in Patients With Recalcitrant Dermatomyositis), which is not on this map. Cited by 757 papers.

0numbers the graph read from it
0cells of the map it votes in
757citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03529955 phase2completednot on this mapstarted 2018, after this paper: background citation

A Phase 2, Open Label Single Arm Study for Evaluating Safety & Efficacy of Apremilast in the Treatment of Cutaneous Disease in Patients With Recalcitrant Dermatomyositis

TypeinterventionalSponsorTulane UniversityRan2018 to 2021Enrolled8ConditionsDermatomyositis, Adult TypeArmsApremilast 30mg
3 · Its place in the literature

Who cites it

757 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

697 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

  • Erratum issued
5 · Who and what money

Authors and funding

10 authors.

Ning LengDepartment of Statistics, University of Wisconsin, Madison, WI 53706, USA.
John A Dawson
James A Thomson
Victor Ruotti
Anna I Rissman
Bart M G Smits
Jill D Haag
Michael N Gould
Ron M Stewart
Christina Kendziorski

Funding

Research Training for Computation and Informatics in Biology and MedicineT15LM007359 · NLM · UNIVERSITY OF WISCONSIN-MADISON · PI Mark W. Craven, Colin Noel Dewey · 2002 to 2026
$22.6M
Statistical methods for spatial RNA sequencing experimentsR01GM102756 · NIGMS · UNIVERSITY OF WISCONSIN-MADISON · PI KENDZIORSKI, CHRISTINA · 2012 to 2024
$3.8M
UAB Statistical Genetics Post-Doctoral Training ProgramT32HL072757 · NHLBI · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI TIWARI, HEMANT K. · 2003 to 2016
$3.8M
FACTORS CONTROLLING SUSCEPTIBILITY TO MAMMARY CANCERR01CA028954 · NCI · UNIVERSITY OF WISCONSIN-MADISON · PI GOULD, MICHAEL N · 1985 to 2009
$3.3M
Breast Cancer GWAS: Function and Environmental InteractionsR01ES017400 · NIEHS · UNIVERSITY OF WISCONSIN-MADISON · PI GOULD, MICHAEL N, NEWTON, MICHAEL A · 2009 to 2013
$2.1M
NCI NIH HHS CA28954NCI NIH HHS R01 CA028954NHLBI NIH HHS T32 HL072757NIEHS NIH HHS R01 ES017400NIGMS NIH HHS GM102756NIGMS NIH HHS R01 GM102756NLM NIH HHS T15 LM007359
6 · The paper itself

Abstract

motivationMessenger RNA expression is important in normal development and differentiation, as well as in manifestation of disease. RNA-seq experiments allow for the identification of differentially expressed (DE) genes and their corresponding isoforms on a genome-wide scale. However, statistical methods are required to ensure that accurate identifications are made. A number of methods exist for identifying DE genes, but far fewer are available for identifying DE isoforms. When isoform DE is of interest, investigators often apply gene-level (count-based) methods directly to estimates of isoform counts. Doing so is not recommended. In short, estimating isoform expression is relatively straightforward for some groups of isoforms, but more challenging for others. This results in estimation uncertainty that varies across isoform groups. Count-based methods were not designed to accommodate this varying uncertainty, and consequently, application of them for isoform inference results in reduced power for some classes of isoforms and increased false discoveries for others.

resultsTaking advantage of the merits of empirical Bayesian methods, we have developed EBSeq for identifying DE isoforms in an RNA-seq experiment comparing two or more biological conditions. Results demonstrate substantially improved power and performance of EBSeq for identifying DE isoforms. EBSeq also proves to be a robust approach for identifying DE genes. AVAILABILITY AND IMPLEMENTATION: An R package containing examples and sample datasets is available at http://www.biostat.wisc.edu/kendzior/EBSEQ/. SUPPLEMENTARY INFORMATION: Supplementary data are available at Bioinformatics online.

Indexed as

Bayes TheoremCell LineEmbryonic Stem CellsGene Expression ProfilingGenomeModels, StatisticalRNA IsoformsRNA, MessengerSequence Analysis, RNASoftwareRNA IsoformsRNA, Messenger

Identifiers

PMID23428641
PMCPMC3624807

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.